Abbott partnered with Flatiron Health to integrate Abbott’s precision oncology testing menu into Flatiron’s cloud-based electronic medical record platform, OncoEMR. The integration enables oncologists to order Abbott tests individually or in combination and receive status updates and results inside their existing clinical workflow across Flatiron’s network of more than 1,600 community cancer care centers. Reported tests include Oncotype DX Breast Recurrence Score, OncoExTra, Oncodetect, and Riskguard assays. The operational shift matters for adoption because embedding ordering and results delivery directly in EHR systems can reduce turnaround friction and improve clinician usability.